Publication: Molecular Surveillance Identifies Multiple Transmissions of Typhoid in West Africa
dc.contributor.author | Vanessa K. Wong | en_US |
dc.contributor.author | Kathryn E. Holt | en_US |
dc.contributor.author | Chinyere Okoro | en_US |
dc.contributor.author | Stephen Baker | en_US |
dc.contributor.author | Derek J. Pickard | en_US |
dc.contributor.author | Florian Marks | en_US |
dc.contributor.author | Andrew J. Page | en_US |
dc.contributor.author | Grace Olanipekun | en_US |
dc.contributor.author | Huda Munir | en_US |
dc.contributor.author | Roxanne Alter | en_US |
dc.contributor.author | Paul D. Fey | en_US |
dc.contributor.author | Nicholas A. Feasey | en_US |
dc.contributor.author | François Xavier Weill | en_US |
dc.contributor.author | Simon Le Hello | en_US |
dc.contributor.author | Peter J. Hart | en_US |
dc.contributor.author | Samuel Kariuki | en_US |
dc.contributor.author | Robert F. Breiman | en_US |
dc.contributor.author | Melita A. Gordon | en_US |
dc.contributor.author | Robert S. Heyderman | en_US |
dc.contributor.author | Jan Jacobs | en_US |
dc.contributor.author | Octavie Lunguya | en_US |
dc.contributor.author | Chisomo Msefula | en_US |
dc.contributor.author | Calman A. MacLennan | en_US |
dc.contributor.author | Karen H. Keddy | en_US |
dc.contributor.author | Anthony M. Smith | en_US |
dc.contributor.author | Robert S. Onsare | en_US |
dc.contributor.author | Elizabeth De Pinna | en_US |
dc.contributor.author | Satheesh Nair | en_US |
dc.contributor.author | Ben Amos | en_US |
dc.contributor.author | Gordon Dougan | en_US |
dc.contributor.author | Stephen Obaro | en_US |
dc.contributor.author | Julian Parkhill | en_US |
dc.contributor.author | Robert A. Kingsley | en_US |
dc.contributor.author | Nicholas R. Thomson | en_US |
dc.contributor.author | Jacqueline A. Keane | en_US |
dc.contributor.author | Jane Hawkey | en_US |
dc.contributor.author | David J. Edwards | en_US |
dc.contributor.author | Zoe A. Dyson | en_US |
dc.contributor.author | Simon R. Harris | en_US |
dc.contributor.author | Amy K. Cain | en_US |
dc.contributor.author | James Hadfield | en_US |
dc.contributor.author | Elizabeth J. Klemm | en_US |
dc.contributor.author | Conall H. Watson | en_US |
dc.contributor.author | W. John Edmunds | en_US |
dc.contributor.author | Nga Tran Vu Thieu | en_US |
dc.contributor.author | Mike Kama | en_US |
dc.contributor.author | Kylie Jenkins | en_US |
dc.contributor.author | Shanta Dutta | en_US |
dc.contributor.author | Josefina Campos | en_US |
dc.contributor.author | Corinne Thompson | en_US |
dc.contributor.author | Christiane Dolecek | en_US |
dc.contributor.author | Christopher M. Parry | en_US |
dc.contributor.author | Abhilasha Karkey | en_US |
dc.contributor.author | E. Kim Mulholland | en_US |
dc.contributor.author | James I. Campbell | en_US |
dc.contributor.author | Sabina Dongol | en_US |
dc.contributor.author | Buddha Basnyat | en_US |
dc.contributor.author | Amit Arjyal | en_US |
dc.contributor.author | Muriel Dufour | en_US |
dc.contributor.author | Don Bandaranayake | en_US |
dc.contributor.author | Take N. Toleafoa | en_US |
dc.contributor.author | Shalini Pravin Singh | en_US |
dc.contributor.author | Mochammad Hatta | en_US |
dc.contributor.author | Lupeoletalalelei Isaia | en_US |
dc.contributor.other | Wellcome Trust Sanger Institute | en_US |
dc.contributor.other | Addenbrooke's Hospital | en_US |
dc.contributor.other | Bio21 Molecular Science and Biotechnology Institute | en_US |
dc.contributor.other | University of Melbourne | en_US |
dc.contributor.other | UCL | en_US |
dc.contributor.other | Nuffield Department of Clinical Medicine | en_US |
dc.contributor.other | London School of Hygiene & Tropical Medicine | en_US |
dc.contributor.other | International Vaccine Institute, Seoul | en_US |
dc.contributor.other | International Foundation Against Infectious Diseases in Nigeria (IFAIN) | en_US |
dc.contributor.other | Aminu Kano Teaching Hospital | en_US |
dc.contributor.other | University of Nebraska Medical Center | en_US |
dc.contributor.other | Liverpool School of Tropical Medicine | en_US |
dc.contributor.other | Institut Pasteur, Paris | en_US |
dc.contributor.other | University of Birmingham | en_US |
dc.contributor.other | St George's University of London | en_US |
dc.contributor.other | Kenya Medical Research Institute | en_US |
dc.contributor.other | Centers for Disease Control and Prevention | en_US |
dc.contributor.other | Emory Global Health Institute | en_US |
dc.contributor.other | University of Liverpool | en_US |
dc.contributor.other | University of Malawi College of Medicine | en_US |
dc.contributor.other | Prins Leopold Instituut voor Tropische Geneeskunde | en_US |
dc.contributor.other | KU Leuven | en_US |
dc.contributor.other | National Institute for Biomedical Research | en_US |
dc.contributor.other | University Hospital of Kinshasa | en_US |
dc.contributor.other | University of Witwatersrand | en_US |
dc.contributor.other | Public Health England | en_US |
dc.contributor.other | St Augustine's Hospital | en_US |
dc.contributor.other | University of Abuja | en_US |
dc.contributor.other | Bingham University | en_US |
dc.contributor.other | Quadram Institute Bioscience | en_US |
dc.contributor.other | Universidad de la Republica Instituto de Higiene | en_US |
dc.contributor.other | Ministry of Health | en_US |
dc.contributor.other | Fiji Health Sector Support Program | en_US |
dc.contributor.other | National Institute of Cholera and Enteric Diseases India | en_US |
dc.contributor.other | ANLIS-Carlos G Malbran Institute | en_US |
dc.contributor.other | Nagasaki University | en_US |
dc.contributor.other | Oxford University Clinical Research Unit | en_US |
dc.contributor.other | Murdoch Children's Research Institute | en_US |
dc.contributor.other | Institute of Environmental Science and Research Limited (ESR) | en_US |
dc.contributor.other | ESR - Kenepuru Science Centre | en_US |
dc.contributor.other | Samoa Ministry of Health | en_US |
dc.contributor.other | Organisation Mondiale de la Sante | en_US |
dc.contributor.other | Hasanuddin University | en_US |
dc.contributor.other | Tupua Tamasese Meaole Hospital | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Angkor Hospital for Children | en_US |
dc.contributor.other | University of Otago | en_US |
dc.contributor.other | Cardiff University | en_US |
dc.contributor.other | Barts and The London NHS Trust | en_US |
dc.contributor.other | University of Cambridge | en_US |
dc.date.accessioned | 2018-12-11T03:25:14Z | |
dc.date.accessioned | 2019-03-14T08:02:05Z | |
dc.date.available | 2018-12-11T03:25:14Z | |
dc.date.available | 2019-03-14T08:02:05Z | |
dc.date.issued | 2016-09-22 | en_US |
dc.description.abstract | © 2016 Public Library of Science. All rights reserved. Background: The burden of typhoid in sub-Saharan African (SSA) countries has been difficult to estimate, in part, due to suboptimal laboratory diagnostics. However, surveillance blood cultures at two sites in Nigeria have identified typhoid associated with Salmonella enterica serovar Typhi (S. Typhi) as an important cause of bacteremia in children. Methods: A total of 128 S. Typhi isolates from these studies in Nigeria were whole-genome sequenced, and the resulting data was used to place these Nigerian isolates into a worldwide context based on their phylogeny and carriage of molecular determinants of antibiotic resistance. Results: Several distinct S. Typhi genotypes were identified in Nigeria that were related to other clusters of S. Typhi isolates from north, west and central regions of Africa. The rapidly expanding S. Typhi clade 4.3.1 (H58) previously associated with multiple antimicrobial resistances in Asia and in east, central and southern Africa, was not detected in this study. However, antimicrobial resistance was common amongst the Nigerian isolates and was associated with several plasmids, including the IncHI1 plasmid commonly associated with S. Typhi. Conclusions: These data indicate that typhoid in Nigeria was established through multiple independent introductions into the country, with evidence of regional spread. MDR typhoid appears to be evolving independently of the haplotype H58 found in other typhoid endemic countries. This study highlights an urgent need for routine surveillance to monitor the epidemiology of typhoid and evolution of antimicrobial resistance within the bacterial population as a means to facilitate public health interventions to reduce the substantial morbidity and mortality of typhoid. | en_US |
dc.identifier.citation | PLoS Neglected Tropical Diseases. Vol.10, No.9 (2016) | en_US |
dc.identifier.doi | 10.1371/journal.pntd.0004781 | en_US |
dc.identifier.issn | 19352735 | en_US |
dc.identifier.issn | 19352727 | en_US |
dc.identifier.other | 2-s2.0-84992386056 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/41138 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84992386056&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | Molecular Surveillance Identifies Multiple Transmissions of Typhoid in West Africa | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84992386056&origin=inward | en_US |